$AMST

Amesite Inc.

Amesite is a technology company that develops and commercializes AI-powered solutions for enterprises and professionals, with an emphasis on post-acute healthcare. Its two product lines are NurseMagic™, which serves individual nurses and caregivers through a consumer app and healthcare businesses through an enterprise application, and LynkMagic™, which provides enterprise AI solutions for healthcare and related organizations. Amesite also offers Amesite Engage, an AI-powered platform for professional, educational and individual needs. The products support documentation, workflow, compliance and oversight. Amesite offers NurseMagic™ in free and subscription tiers, with enterprise standard and customized models, and sells its enterprise solutions to healthcare organizations including home health, skilled nursing and hospice providers. Amesite is headquartered in Detroit, Michigan.

3
0
1

No SEC Form 4 filings for $AMST in the last 30 days.

See all $AMST insider activity →
Low

Amesite Signs NurseMagic Enterprise Agreement Serving 2,000 Patients

Amesite Inc. (AMST) signed a NurseMagic enterprise agreement with a healthcare provider serving 2,000 patients, expanding its customer base. The deal is expected to boost revenue and user base, though no contract value was disclosed. NurseMagic automates documentation and EMR workflows within existing systems, and Amesite claims it can deploy customer-specific capabilities quickly.

AMST sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 4 news stories mentioning AMST (Amesite Inc.). Coverage has skewed bullish: 3 bullish, 0 neutral, and 1 bearish.

Recent AMST coverage spans financial news and corporate actions.

What's driving AMST

  • Enterprise agreement expansion should support incremental revenue and user growth, but lack of disclosed contract value limits near-term earnings visibility.

    tradingview.com · Nov 17, 2026

  • The disclosed enterprise customer win is likely to be viewed as incremental growth validation for Amesite’s NurseMagic subscription model.

    SEC EDGAR 8-K · Nov 17, 2026

  • Potential delisting pressure may drive the stock lower.

    tradingview.com · Nov 13, 2026

  • The filing discloses an ATM equity issuance mechanism, which can increase dilution risk and affect near-term valuation and liquidity expectations.

    SEC EDGAR 8-K · Jul 20, 2026

  • Shareholder approval expands AMST’s equity compensation capacity and authorizes additional shares tied to Series A-1 and A-2 warrant exercises.

    SEC EDGAR 8-K · Jul 13, 2026

AlphAI scores every news story that mentions AMST with an AI model for sentiment and relevance, and aggregates insider trades from Amesite Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $AMST

Score

Amesite Signs NurseMagic Enterprise Agreement Serving 2,000 Patients

Amesite Inc. (AMST) signed a NurseMagic enterprise agreement with a healthcare provider serving 2,000 patients, expanding its customer base. The deal is expected to boost revenue and user base, though no contract value was disclosed. NurseMagic automates documentation and EMR workflows within existing systems, and Amesite claims it can deploy customer-specific capabilities quickly.

$AMSTMedContract· supplier

Amesite Signs New 2,000-Patient NurseMagic® Enterprise Customer, Extending Growth Among Large Healthcare Organizations

Amesite Inc. (AMST) filed an SEC Form 8-K — Other Events. Exhibit 99.1 Amesite Signs New 2,000-Patient NurseMagic ® Enterprise Customer, Extending Growth Among Large Healthcare Organizations Amesite announces its latest major enterprise win, increasing its revenue and deploying AI automations for another large healthcare organization in

$AMSTMedOffering· definitive

Amesite Inc. (AMST): Entry into a Material Definitive Agreement

Amesite Inc. (AMST) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 3 ea029847801ex10-1.htm AT THE MARKET OFFERING AGREEMENT DATED JULY 17, 2026 BETWEEN AMESITE INC. AND H.C. WAINWRIGHT & CO., LLC Exhibit 10.1 AT THE MARKET OFFERING AGREEMENT July 17, 2026 H.C. Wainwright & Co., LLC 430 Park Avenue New York, New York 10022 Ladies and Gent

$AMSTLowShareholder vote

Amesite Inc. (AMST): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Amesite Inc. (AMST) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. false 0001807166 0001807166 2026-07-13 2026-07-13 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Repor

Amesite’s NurseMagic™ Wins 2,700-Census Home Care Enterprise Customer

Amesite Inc. announced that its AI-native NurseMagic™ documentation platform secured a new enterprise customer with an approximately 2,700-patient census, marking its largest deployment yet. This win validates NurseMagic™’s scalable architecture and AI-first approach for non-acute care, demonstrating its ability to streamline workflows, integrate EMR and EVV, and significantly reduce administrative burden for caregivers while maintaining financial discipline. The company expects continued automation efficiencies to benefit unit economics as it scales into larger enterprises.

Amesite announces $2M registered direct offering at $1.44/share By Investing.com

Amesite Inc. has announced a registered direct offering and concurrent private placement to raise approximately $2 million. The company will sell 696,866 shares of common stock at $1.435 per share, along with issuing warrants, and an additional 696,866 shares or pre-funded warrants in a private placement. The net proceeds are intended for general corporate purposes, including working capital, as the company shows strong revenue growth despite a decline in its stock price.

Amesite gets $2M now, with another $4M tied to warrants

Amesite (Nasdaq: AMST) announced a concurrent registered direct offering and private placement to raise up to $6 million. The company expects to receive approximately $2 million upfront from the sale of shares and up to an additional $4 million if the issued warrants are fully exercised. This financing, priced at-the-market under Nasdaq rules, is intended for general corporate purposes, including working capital, but has led to a significant negative market reaction, with AMST stock declining over 25%.

[RW] Amesite Inc. SEC Filing

Amesite Inc. has filed Form RW with the SEC, requesting the immediate withdrawal of its S-1 Registration Statement (File No. 333-295187). The company stated it has elected not to pursue the sale of securities contemplated by the Registration Statement at this time, and confirmed no securities were sold. The filing was made on April 23, 2026, and indicates a neutral impact and sentiment.

Related tickers